secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2024-03-06T23:59:59+00:00
Accession:  0001104659-24-031475
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals underwriters exercise overallotment, issue 750K shares at $0.30
--------------------------------------------------------------------------------

- Underwriters exercised overallotment option for 750,000 shares at $0.30/share, closed March 6, 2024.
- Option shares are part of the underwritten public offering announced Feb 27, 2024, with EF Hutton as lead underwriter.
- Gross proceeds from the option exercise total approximately $225,000 before underwriting discounts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924031475/0001104659-24-031475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000110465924031475/tm248115d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-031475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer